Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.
2.

Further characterization of a pathological isoantithrombin with no affinity for heparin (antithrombin III Roma).

De Stefano V, Leone G, Ferrelli R, Di Donfrancesco A, De Martini D, Bizzi B.

Thromb Res. 1987 Oct 1;48(1):23-30.

PMID:
3424283
3.
4.

Microheterogeneity of antithrombin III: effect of single amino acid substitutions and relationship with functional abnormalities.

De Stefano V, Leone G, Mastrangelo S, Lane DA, Girolami A, de Moerloose P, Sas G, Abildgaard U, Blajchman M, Rodeghiero F, et al.

Blood Coagul Fibrinolysis. 1994 Feb;5(1):7-15.

PMID:
8180341
5.

Abnormal antithrombin III with defective serine protease binding (antithrombin III "Denver").

Sambrano JE, Jacobson LJ, Reeve EB, Manco-Johnson MJ, Hathaway WE.

J Clin Invest. 1986 Mar;77(3):887-93.

6.

Antithrombin III in full-term and pre-term newborn infants: three cases of neonatal diagnosis of AT III congenital defect.

De Stefano V, Leone G, De Carolis MP, Ferrelli R, De Carolis S, Pagano L, Tortorolo G, Bizzi B.

Thromb Haemost. 1987 Jun 3;57(3):329-31.

PMID:
3660333
7.

Quantitative and qualitative congenital deficiency of antithrombin III: a new molecular variant called ATIII-Barcelona 2.

Fontcuberta J, Grau E, Rubio N, Félez J, Rutllant ML.

Thromb Res. 1988 Jul 1;51(1):75-81.

PMID:
3413737
8.

AT III Barcelona: a familial quantitative-qualitative AT III deficiency.

Grau E, Fontcuberta J, Félez J, de Diego I, Soto R, Rutllant ML.

Thromb Haemost. 1988 Feb 25;59(1):13-7.

PMID:
3363529
9.

Different forms of AT-III congenital defect: a study by crossed immunoelectrofocusing.

Leone G, Cotumaccio R, De Stefano V, Zanetti L, Bizzi B.

Scand J Haematol. 1984 Nov;33(5):410-7.

PMID:
6515325
10.

Characterization of an abnormal antithrombin (Milano 2) with defective thrombin binding.

Tripodi A, Krachmalnicoff A, Mannucci PM.

Thromb Haemost. 1986 Dec 15;56(3):349-52.

PMID:
3563966
11.

Antithrombin Milano: a new variant with monomeric and dimeric inactive antithrombin III.

Wolf M, Boyer C, Tripodi A, Meyer D, Larrieu MJ, Mannucci PM.

Blood. 1985 Feb;65(2):496-500.

12.

Human antithrombin III heterogeneity: a study by isoelectrofocusing and crossed immunoelectrofocusing.

Leone G, Valori VM, Cotumaccio R, Massi G.

Haemostasis. 1983;13(6):369-73.

PMID:
6667904
13.

Purification and characterization of hereditary abnormal antithrombin III with impaired thrombin binding.

Jørgensen M, Petersen LC, Thorsen S.

J Lab Clin Med. 1984 Aug;104(2):245-56.

PMID:
6747440
14.

An abnormal antithrombin III (AT III) with low heparin affinity: AT III Clichy.

Aiach M, François D, Priollet P, Capron L, Roncato M, Alhenc-Gelas M, Fiessinger JN.

Br J Haematol. 1987 Aug;66(4):515-22.

PMID:
3663508
16.

Antithrombin III Alger: a new homozygous AT III variant.

Fischer AM, Cornu P, Sternberg C, Mériane F, Dautzenberg MD, Chafa O, Beguin S, Desnos M.

Thromb Haemost. 1986 Apr 30;55(2):218-21.

PMID:
3715788
17.

Antithrombin III Toyama: a hereditary abnormal antithrombin III of a patient with recurrent thrombophlebitis.

Sakuragawa N, Takahashi K, Kondo S, Koide T.

Thromb Res. 1983 Jul 15;31(2):305-17.

PMID:
6636045
18.

Heterogeneity of the "classical" antithrombin III deficiency.

Sas G, Petö I, Bánhegyi D, Blaskó G, Domján G.

Thromb Haemost. 1980 Jun 18;43(2):133-6.

PMID:
7455972
19.

Antithrombin-III-Stockholm: a codon 392 (Gly----Asp) mutation with normal heparin binding and impaired serine protease reactivity.

Blajchman MA, Fernandez-Rachubinski F, Sheffield WP, Austin RC, Schulman S.

Blood. 1992 Mar 15;79(6):1428-34.

20.
Items per page

Supplemental Content

Write to the Help Desk